D. Boral Capital Reaffirms “Buy” Rating for VolitionRx (NYSE:VNRX)
VolitionRx (NYSE:VNRX – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at D. Boral Capital in a report released on Thursday,Benzinga reports. They presently have a $5.00 price target on the stock. A number of other equities analysts have also recently issued reports on the stock. Benchmark restated a “hold” rating […]
VolitionRx (NYSE:VNRX – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at D. Boral Capital in a report released on Thursday,Benzinga reports. They presently have a $5.00 price target on the stock. A number of other equities analysts have also recently issued reports on the stock. Benchmark restated a “hold” rating […]
